• Fetal and neonatal haemolysis, sometimes resulting in death or brain damage. Caused by maternal antibodies to red cell antigens (usually Rh D, although antibodies to Rh c and to blood groups of other systems such as Kell, Duffy, Kidd, and Cellano may produce haemolysis by the same mechanism). Anti-D occurs in Rh D negative women who have been exposed to D positive blood (usually from a D positive fetus), and crosses the placenta.
Prevalence
• In unscreened white populations, about 1% of all births (10% of the 60% D positive offspring of the 15% of mothers who are Rh negative).'
Screening procedures
• In pregnant women, Rh blood grouping and qualitative tests for red cell antibodies. Performed at first visit to antenatal clinic. Antibody test (if negative) repeated at 28-36 weeks' gestation. • In newborn, direct antiglobulin (Coombs's) test for blood group antibodies on cord blood red cells.
Subsequent tests
• If pregnant woman is antibody positive, antibody titration, followed if titre is high by amniocentesis to determine bilirubin level in amniotic fluid, and/or by fetal blood sampling to establish degree of fetal anaemia and hyperbilirubinaemia. • If newborn is Coombs positive, tests on cord blood to establish haemoglobin and bilirubin levels and on capillary blood to monitor these levels. • If newborn is Coombs negative but Rh positive, and mother is Rh negative, test for maternal blood group antibodies.
Interoention
• In a Rh negative woman anti-D should be given after miscarriage, antepartum haemorrhage, intrauterine procedures, and delivery of a Rh positive Coombs's test negative infant; prophylaxis at 28 or 34 weeks is being considered. • In an affected pregnancy, delivery after 34 weeks' gestation; fetal transfusions for fetuses younger than this or if hydropic. • In affected newborn, exchange transfusion.
Outcome
• The main evidence for the value of the programme is the decline in morbidity and mortality. In the mid-1960s, before screening and the use of anti-D were introduced to prevent active D immunity in Rh negative women, approximately 1% of all infants were affected by Rh haemolytic disease of the newborn and 15% of these infants died. During the next 20 years the incidence fell to about 0'15% and the mortality to less than 2% of those affected in Manitoba.' • In England and Wales, 313 perinatal deaths occurred related to haemolytic disease of the newborn were reported in 1973 2 compared with nine in 1993. 3
